Sensei Biotherapeutics, Inc. (SNSE)

NASDAQ: SNSE · IEX Real-Time Price · USD

1.260

+0.250 (24.75%)

At close: May 1, 2024, 4:00 PM

1.280

+0.020 (1.59%)

Pre-market: May 2, 2024, 4:30 AM EDT

Sensei Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	32	17	46	177	-	-	-
Market Cap Growth	-	-62.21%	-74.21%	-	-	-	-
Enterprise Value	-28	-42	-53	32	-16	15	4
PE Ratio	-0.51	-0.51	-0.94	-4.82	-	-	-
PB Ratio	0.49	0.27	0.44	1.21	-	-	-
P/FCF Ratio	-0.54	-0.54	-1.16	-5.55	-	-	-
P/OCF Ratio	-0.54	-0.54	-1.17	-5.86	-	-	-
EV/EBITDA Ratio	1.35	1.35	1.16	-0.91	0.87	-1.07	-0.29
EV/EBIT Ratio	1.24	1.24	1.10	-0.89	0.86	-1.06	-0.29
EV/FCF Ratio	1.32	1.32	1.36	-1.01	0.84	-1.78	-0.35
Debt / Equity Ratio	0.10	0.10	0.08	0.02	-0.01	-0.23	-0.09
Debt / EBITDA Ratio	-0.20	-0.20	-0.18	-0.07	-0.04	-1.11	-0.37
Debt / FCF Ratio	-0.19	-0.19	-0.20	-0.07	-0.04	-1.86	-0.46
Quick Ratio	11.65	11.65	11.82	30.19	3.44	0.03	0.41
Current Ratio	11.92	11.92	11.98	30.38	4.16	0.02	0.48
Interest Coverage	-235.81	-235.81	-220.86	-53.92	-10.90	-6.42	-38.87
Return on Equity (ROE)	-44.00%	-44.00%	-40.60%	-23.10%	32.30%	33.60%	-
Return on Assets (ROA)	-38.60%	-38.60%	-36.30%	-22.40%	-178.40%	-1339.70%	-
Return on Capital (ROIC)	-52.13%	-52.13%	-45.04%	-25.18%	34.88%	23.64%	26.14%
Earnings Yield	-107.95%	-197.14%	-106.15%	-20.73%	-	-	-
FCF Yield	-101.42%	-185.21%	-85.93%	-18.01%	-	-	-
Buyback Yield / Dilution	8.96%	8.96%	-10.80%	-1618.88%	-338.85%	97.92%	-
Total Shareholder Return	8.96%	8.96%	-10.80%	-1618.88%	-338.85%	97.92%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).